IntriCon Corporation (NASDAQ:IIN) is set to announce second quarter earning results on Monday 10th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, IIN to report 2Q20 loss of $ 0.29 per share.
For the full year, analysts anticipate top line of $ 93.40 million, while looking forward to loss of $ 0.5 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 110.00 million ~ $ 114.00 million
Click Here For More Historical Outlooks Of IntriCon Corporation
Previous Quarter Performance
IntriCon Corporation disclosed loss for the first quarter of $ 0.22 per share, from the revenue of $ 21.50 million. The quarterly revenues shrunk 28.12 percent compared with the same quarter last year. According to street consensus, IIN was expected to report 1Q20 loss of $ 0.09 per share from revenue of $ 23.28 million. The bottom line results missed street analysts by $ 0.13 or 144.44 percent, at the same time, top line results fell short of analysts by $ 1.78 million or 7.65 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of IntriCon Corporation
Stock Performance
According to the previous trading day, closing price of IIN was $ 11.66, representing a 18.50 % increase from the 52 week low of $ 9.84 and a 48.11 % decrease over the 52 week high of $ 22.47.
The company has a market capital of $ 103.79 million and is part of the Technology sector and Electronic Components industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”IIN” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
IntriCon Corporation will be hosting a conference call at 5:00 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.intricon.com
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.
